1-2 of 2
John Bothos, PhD
Close
Save search
Sort by
Journal Articles

Ibrutinib Vs Temsirolimus: Results from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL)

Free
Simon Rule, MD, Wojciech Jurczak, MD PhD, Mats Jerkeman, MD PhD, Rodrigo Santucci, MD, Chiara Rusconi, MD, Marek Trneny, MD, PhD, Prof., Fritz Offner, MD PhD, Dolores Caballero, MD, Cristina Joao, MD PhD MSc, Mathias Witzens-Harig, MD, Georg Hess, MD, Isabelle Bence-Bruckler, MD FRCPC, Seok-Goo Cho, MD, Sriram Balasubramanian, PhD, Nibedita Bandyopadhyay, PhD, Steven Sun, PhD, Jenna Goldberg, MD, John Bothos, PhD, Shana Traina, PhD, Christopher Enny, BS, Aleksandra Rizo, MD, Jessica Vermeulen, MD PhD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 469.
https://doi.org/10.1182/blood.V126.23.469.469
Published: 2015
Journal Articles

Lymphoma Symptoms: Data from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL) Treated with Ibrutinib Vs. Temsirolimus

Free
Georg Hess, MD, Simon Rule, MD, Wojciech Jurczak, Mats Jerkeman, MD PhD, Rodrigo Santucci, MD, Chiara Rusconi, MD, Dolores Caballero, Cristina M. Joao, MD PhD, Mathias Witzens-Harig, MD, Isabelle Bence-Bruckler, MD FRCPC, Seok-Goo Cho, Nibedita Bandyopadhyay, PhD, Jenna Goldberg, MD, John Bothos, PhD, Christopher Enny, BS, Jessica Vermeulen, MD PhD, Shana Traina, PhD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1542.
https://doi.org/10.1182/blood.V126.23.1542.1542
Published: 2015